Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.24.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
IPO
Ratchet
At-The-Market Financing
Follow-on Offering
Babyshelf Offering
Common Stock
Common Stock
IPO
Common Stock
Ratchet
Common Stock
At-The-Market Financing
Common Stock
Follow-on Offering
Common Stock
Babyshelf Offering
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Ratchet
Additional Paid-In Capital
At-The-Market Financing
Additional Paid-In Capital
Follow-on Offering
Additional Paid-In Capital
Babyshelf Offering
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2021 $ 9,181,203           $ 758           $ 37,618,438           $ (28,437,993)  
Balance, Shares at Dec. 31, 2021             7,584,980                          
Issuance of common shares upon exercise of stock options 84,000           $ 5           83,995              
Issuance of common shares upon exercise of stock options, Shares             46,500                          
Issuance of common shares upon exercise of warrants 385,400           $ 53           385,347              
Issuance of common shares upon exercise of warrants, Shares             529,712                          
Stock-based compensation expense 2,319,427                       2,319,427              
Issuance of common shares in connection with equity financing 2,473,560           $ 28           2,473,532              
Issuance of common shares in connection with equity financing, Shares             274,840                          
Issuance of common shares   $ 8,750,095 $ 1,099,360         $ 230 $ 22         $ 8,749,865 $ 1,099,338          
Issuance of common shares, Shares               2,300,000 219,872                      
Modification of warrant in equity 450,578                       450,578              
Deemed dividend on modification of warrant (450,578)                       (450,578)              
Foreign currency translation adjustment (15,973)                       0             $ (15,973)
Net loss (15,769,279)                                   (15,769,279)  
Balance at Dec. 31, 2022 8,507,793           $ 1,096           52,729,942           (44,207,272) (15,973)
Balance, Shares at Dec. 31, 2022             10,955,904                          
Issuance of common shares upon exercise of stock options $ 1,433           $ 1           1,432              
Issuance of common shares upon exercise of stock options, Shares 750           750                          
Issuance of restricted common shares $ 731,661           $ 28           731,633              
Issuance of restricted common shares, Shares             291,469                          
Stock-based compensation expense 3,089,304                       3,089,304              
Issuance of stock options to satisfy accrued bonus 974,224                       974,224              
Issuance of common shares       $ 1,154,437 $ 4,156,859 $ 1,393,883       $ 76 $ 256 $ 242       $ 1,154,361 $ 4,156,603 $ 1,393,641    
Issuance of common shares, Shares                   758,388 2,555,500 2,424,243                
Issuance of warrants to underwriter in connection with initial public offering 241,109                       241,109              
Foreign currency translation adjustment (287)                                     (287)
Net loss (19,772,905)                                   (19,772,905)  
Balance at Dec. 31, 2023 $ 477,511           $ 1,699           $ 64,472,249           $ (63,980,177) $ (16,260)
Balance, Shares at Dec. 31, 2023             16,986,254